Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.69
+0.25 (2.01%)
At close: Jul 14, 2025, 4:00 PM
12.58
-0.11 (-0.87%)
After-hours: Jul 14, 2025, 6:07 PM EDT

Nurix Therapeutics Balance Sheet

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2018 - 2019
Cash & Equivalents
84.2611054.6364.4780.51119.36
Upgrade
Short-Term Investments
401.52499.59233.28244.67215.21161.79
Upgrade
Cash & Short-Term Investments
485.78609.58287.91309.14295.72281.15
Upgrade
Cash Growth
9.62%111.73%-6.87%4.54%5.18%645.36%
Upgrade
Accounts Receivable
19---67.5
Upgrade
Other Receivables
1.71.50.81.11.14.25
Upgrade
Receivables
20.71.50.81.17.111.75
Upgrade
Prepaid Expenses
8.858.36.88.218.295.54
Upgrade
Total Current Assets
515.33619.39295.5318.45311.12298.43
Upgrade
Property, Plant & Equipment
68.9945.947.9529.5125.356.67
Upgrade
Long-Term Investments
--7.4263.88137.1990.89
Upgrade
Long-Term Deferred Charges
-0.10.50.50.5-
Upgrade
Other Long-Term Assets
7.243.964.224.422.620.35
Upgrade
Total Assets
591.56669.34355.6416.76476.77396.34
Upgrade
Accounts Payable
5.9511.486.45.066.653.41
Upgrade
Accrued Expenses
35.0534.4824.1920.8413.827.55
Upgrade
Current Portion of Leases
5.248.017.495.533.85-
Upgrade
Current Income Taxes Payable
0.911.240.030.090.080.07
Upgrade
Current Unearned Revenue
27.4238.3648.137.6341.2132.8
Upgrade
Other Current Liabilities
1.042.280.751.50.660.7
Upgrade
Total Current Liabilities
75.6195.8586.9670.6666.2644.54
Upgrade
Long-Term Leases
46.720.2923.136.439.19-
Upgrade
Long-Term Unearned Revenue
21.6426.2145.0235.9759.0260.69
Upgrade
Other Long-Term Liabilities
-----0.85
Upgrade
Total Liabilities
143.95142.35155.11113.06134.47106.07
Upgrade
Common Stock
0.080.080.050.050.050.04
Upgrade
Additional Paid-In Capital
1,2861,266746.3709.22563.76393.84
Upgrade
Retained Earnings
-838.58-738.77-545.2-401.25-220.89-103.7
Upgrade
Comprehensive Income & Other
-0.020.15-0.66-4.32-0.610.09
Upgrade
Total Common Equity
447.6526.99200.49303.7342.3290.27
Upgrade
Shareholders' Equity
447.6526.99200.49303.7342.3290.27
Upgrade
Total Liabilities & Equity
591.56669.34355.6416.76476.77396.34
Upgrade
Total Debt
51.9328.330.6111.9613.04-
Upgrade
Net Cash (Debt)
433.85581.28264.72361.06419.87281.15
Upgrade
Net Cash Growth
2.40%119.59%-26.68%-14.01%49.34%645.36%
Upgrade
Net Cash Per Share
5.458.664.877.439.7917.94
Upgrade
Filing Date Shares Outstanding
76.4575.8948.8947.2744.7438.91
Upgrade
Total Common Shares Outstanding
76.4375.8748.7247.1744.6638.86
Upgrade
Working Capital
439.72523.53208.55247.79244.86253.9
Upgrade
Book Value Per Share
5.866.954.126.447.667.47
Upgrade
Tangible Book Value
447.6526.99200.49303.7342.3290.27
Upgrade
Tangible Book Value Per Share
5.866.954.126.447.667.47
Upgrade
Machinery
45.1541.0433.8327.6219.315.37
Upgrade
Leasehold Improvements
6.235.143.243.833.082.66
Upgrade
Updated Jul 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q